home / stock / adil / adil news

ADIL News and Press, Adial Pharmaceuticals Inc From 11/29/23

Stock Information
Company Name: Adial Pharmaceuticals Inc
Stock Symbol: ADIL
Market: NASDAQ
Website: adialpharma.com
Menu
ADIL ADIL Quote ADIL Short ADIL News ADIL Articles ADIL Message Board
Get ADIL Alerts

News, Short Squeeze, Breakout and More Instantly...
ADIL - Adial Pharmaceuticals regains compliance with Nasdaq listing rule

2023-11-29 16:08:29 ET More on Adial Pharmaceuticals Adial Pharmaceuticals stock plummets on selling 1.42M shares at $2.82 in private placement Seeking Alpha’s Quant Rating on Adial Pharmaceuticals For further details see: Adial Pharmaceuticals regains com...
ADIL - Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement

CHARLOTTESVILLE, Va., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...

ADIL - Adial Pharmaceuticals reports Q3 results

2023-11-14 18:01:17 ET More on Adial Pharmaceuticals Adial Pharmaceuticals stock plummets on selling 1.42M shares at $2.82 in private placement Adial Pharmaceuticals reports Q2 results Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical ea...

ADIL - Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Advancing Discussions with Potential Strategic Partners Received Frost & Sullivan’s 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award Closed $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules; Extends...
ADIL - Expected US Company Earnings on Monday, November 13th, 2023

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

ADIL - Expected earnings - Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc (ADIL) is expected to report $-1.13 for Q3 2023

ADIL - Adial Pharmaceuticals files to sell 4.34M shares of common stock for holders

2023-11-09 08:55:30 ET More on Adial Pharmaceuticals Adial Pharmaceuticals stock plummets on selling 1.42M shares at $2.82 in private placement Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical earnings data for Adial Pharmaceuticals Fin...
ADIL - Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss "New Aspects in Substance Use Treatment" at The Annual International Society of Addiction Medicine Conference

CHARLOTTESVILLE, Va., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and relate...

ADIL - Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar

CHARLOTTESVILLE, Va., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disor...

ADIL - Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CHARLOTTESVILLE, Va., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders,...
Previous 10 Next 10